Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta (Q44597307)
Jump to navigation
Jump to search
scientific article published on 15 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta |
scientific article published on 15 February 2010 |
Statements
1 reference
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta (English)
1 reference
Daniel Wynn
1 reference
Michael Kaufman
1 reference
Xavier Montalban
1 reference
Timothy Vollmer
1 reference
Jack Simon
1 reference
Jacob Elkins
1 reference
Gilmore O'Neill
1 reference
Lauri Neyer
1 reference
James Sheridan
1 reference
Chungchi Wang
1 reference
Alice Fong
1 reference
John W Rose
1 reference
CHOICE investigators
1 reference
15 February 2010
1 reference
1 reference
Identifiers
1 reference